Central Nervous System Drugs Global Market Report 2018 - PowerPoint PPT Presentation

View by Category
About This Presentation
Title:

Central Nervous System Drugs Global Market Report 2018

Description:

The global central nervous system drugs market was valued at around $71 billion in 2017. North America was the largest region in the central nervous system drugs market in 2017, accounting for nearly 40% market share. Read Report – PowerPoint PPT presentation

Number of Views:34
Slides: 14
Provided by: praneethtbrc
Category:

less

Write a Comment
User Comments (0)
Transcript and Presenter's Notes

Title: Central Nervous System Drugs Global Market Report 2018


1
Central Nervous System Global Market Report 2018
Including Anaesthetics Analgesics
Anti-Parkinson drugs Anti-Epileptics Other CNS
drugs Covering Biogen Inc., F. Hoffmann-La
Roche Ltd, Johnson Johnson, Pfizer Inc.,
Novartis AG
Feb 2018
2
Reasons to Purchase
  • Outperform competitors using accurate up to date
    demand-side dynamics information.
  • Identify growth segments for investment.
  • Facilitate decision making on the basis of
    historic and forecast data and the drivers and
    restraints on the market.
  • Create regional and country strategies on the
    basis of local data and analysis.
  • Stay abreast of the latest customer and market
    research findings
  • Benchmark performance against key competitors.
  • Develop strategies based on likely future
    developments.
  • Utilize the relationships between key data sets
    for superior strategizing.
  • Suitable for supporting your internal and
    external presentations with reliable high
    quality data and analysis
  • Gain a global perspective on the development of
    the market.
  • Report will be updated with the latest data and
    delivered to you within 3-5 working days of
    order.
  • Scope
  • Markets Covered Anaesthetics Analgesics
    Anti-Parkinson drugs Anti-Epileptics Other
  • CNS drugs
  • Companies Mentioned Biogen Inc., F. Hoffmann-La
    Roche Ltd, Johnson Johnson, Pfizer Inc.,
    Novartis AG
  • Countries Brazil, China, France, Germany, India,
    Italy, Japan, Spain, Russia, UK, USA and
    Australia.
  • Regions Asia-Pacific, Western Europe, Eastern
    Europe, North America, South America, Middle
    East And Africa

3
Central Nervous System Market
Characteristics
The central nervous system drugs market includes
medications that are used in the treatment of
diseases affecting the brain or spinal cord. The
central nervous system (CNS) integrates sensory
information and instructs the body to respond
accordingly. The spinal cord is a channel for
signals between the brain and the rest of the
body. Central nervous system (CNS) disorder is a
condition in which the brain and spinal cords
ability to function is affected, hence affecting
the body. The market for CNS disorder drugs
comprises of drugs that work in different ways
depending on the type of disease by suppressing
or boosting the brain activities. Top selling
neurological drugs in 2016 include Copaxone,
Lyrica, and Tecfidera. The market numbers within
this briefing are restricted to pharmaceutical
(drug) treatments and do not cover biologic
treatments for these conditions which are
included in a separate briefing. The central
nervous system drugs market can be classified as
follows Analgesics relieves pain selectively
without blocking the conduction of nerve
impulses, noticeably changing sensory Anti-Parkins
on Drugs are used to treat symptoms of
Parkinson's disease and other forms of
Parkinsonism which are caused Anesthetics cause
unconsciousness and unresponsiveness to the body
by suppressing responses to sensory stimulation
in Anti-Epileptics Drugs (AED), also known as
anticonvulsants, are preventative drugs used to
control epileptic seizures, Other central nervous
system drugs include the following Antiemetics
are the drugs used to relieve nausea and vomiting
caused by a various medical conditions and
situations such
4
Muscle Relaxants are a heterogeneous group of
medications that affect skeletal muscle function
to relieve muscle Sedatives are central nervous
system (CNS) depressants that reduce normal brain
functioning. These drugs modulate In this
report market value is defined as the revenues
organizations earn by selling their goods and
services within the specified market, based on
the price at which they sell. Only goods and
services traded between entities are included.
The revenues for a specified geography are
consumption values that is, they are revenues
generated by organizations in the specified
geography within the specified market,
irrespective of where they are produced.
5
Central Nervous System Market
Historic Growth
The global central nervous system market grew
from X billion in 2013 to X billion in 2017 at
a compound annual growth rate (CAGR) of X. The
chart and table below shows the year-on-year
growth of the global central nervous system
market during 2013 2017.
Drivers of the Market Restraints on the Market
6
Central Nervous System Market Forecast Growth
The global Central Nervous System Drugs market
grew from XX billion in 2017 to 87.2 billion
in 2021 at a compound annual growth rate
(CAGR) of XX. Going forward, the growth of
this market can be attributed to steps taken by
the US FDA (Food and Drug Administration) and
EMA (European Medicines Agency) to offer
allotment of special regulatory designations for
Central Nervous System disorders which will help
in the faster entry of drugs into the market for
treatment of serious nervous system related
conditions. The geriatric population and rise in
diseases such as Parkinsons, Alzheimers and
other mental disorders is also likely to
continue to drive the market for central nervous
system drugs in the forecast period. The chart
and table below shows the year-on-year growth of
the global central nervous system market during
2017 - 2021.
7
Drivers of the Market Restraints on the Market
8
Central Nervous System Market Segmentation
The chart and table below shows the split of the
central nervous system market in 2017.
The total market value for central nervous system
was X billion in 2017. The markets that are
covered include Anaesthetics Analgesics
Anti-Parkinson drugs Anti-Epileptics Other CNS
drugs. Anaesthetics was the x largest segment in
the central nervous system market with X share
of the market. The market value for the
anaesthetics was x billion in 2017. Analgesics
made up around X share of the market. The market
value for the analgesics was x billion in 2017.
9
Central Nervous System Market Regional And
Country Analysis
The Asia Pacific was the x largest region in the
central nervous system market in 2017, central
nervous system for X billion or X market
share. North America was the x largest region
central nervous system for X billion or X
market share. Europe was the x largest region
central nervous system for X billion or X
market share.
10
Central Nervous System Market
Competitive Landscape
The leading competitors in the global central
nervous system market are Biogen Inc., F.
Hoffmann-La Roche Ltd, Johnson Johnson, Pfizer
Inc., Novartis AG The chart and table below
displays the percentage market share of the top
players in the central nervous system market
industry.
Biogen Inc. generated revenues of XX billion for
the financial year 2016, an XX increase from
the previous year. F. Hoffmann-La Roche Ltd.
generated revenues of XX billion for the
financial year 2016, an XX increase from the
previous year. Johnson Johnson generated
revenues of XX billion for the financial year
2016, an XX decrease from the previous year.
11
Pfizer Inc. generated revenues of XX billion for
the financial year 2016, an XX increase from
the previous year. Novartis AG generated
revenues of XX billion for the financial year
2016, an XX decrease from the previous
year. Shire Plc. generated revenues of XX
billion for the financial year 2016, an XX
increase from the previous year. UCB S.A.
generated revenues of XX billion for the
financial year 2016, an XX increase from the
previous year. Eli Lilly And Company generated
revenues of XX billion for the financial year
2016, an XX decrease from the previous
year. Sanofi S.A. generated revenues of XX
billion for the financial year 2016, an XX
increase from the previous year. Daiichi Sankyo
Company, Limited generated revenues of XX
billion for the financial year 2016, an XX
decrease from the previous year. Company Profile
Biogen Inc. Overview Biogen Idec was the X
largest company in the central nervous system
drugs market in 2017 with a XX share of the
market. The company was founded in 1978 and is
headquartered in Massachusetts, USA. It is
involved in discovering, developing, and
selling medical products used to treat
neurological disorders such as multiple
sclerosis, and inflammatory diseases
12
such as rheumatoid arthritis. Biogen Idec has
offices in Australia, the Brazil, Japan, India,
and China. Products and Services Biogen Idec
operates through following divisions The
Research And Development Organization division is
engaged in the research and discovery of new
therapy products and supports development
and The Pharmaceutical, Operations And Technology
Organization division is involved in the
development of the manufacturing processes,
clinical trial supply, The Commercial
Organization division manages the development of
the companys products Strategy Biogen Idecs
growth strategy is to develop and expanding its
neurology portfolio. In this regard, the company
acquired UK-based clinical-stage
biopharmaceutical company Convergence
Pharmaceuticals, in January 2015.
Convergence Financial Performance Biogens
Multiple Sclerosis drugs in Pharmaceutical,
Operations And Technology Organization division,
involved in central nervous system drugs
manufacturing, generated revenues of XX billion
for the financial year 2016, a XX decrease
from F. Hoffmann-La Roche Ltd Overview Products
and Services Strategy Financial Performance
13
Johnson Johnson Overview Products and Services
Strategy Financial Performance Pfizer
Inc. Overview Products and Services
Strategy Financial Performance Novartis
AG Overview Products and Services
Strategy Financial Performance
About PowerShow.com